TPI Composites, Inc. to Participate at Upcoming Investor Conferences
Nov 29, 2017 21:05 pm UTC| Business
SCOTTSDALE, Ariz., Nov. 29, 2017 -- TPI Composites, Inc. (“TPI”) (Nasdaq:TPIC), the only independent manufacturer of composite wind blades with a global footprint, today announced that its management team will attend...
Nov 29, 2017 21:05 pm UTC| Business
NEW YORK, Nov. 29, 2017 -- PennantPark Investment Corporation (NASDAQ:PNNT) announced today financial results for the fourth quarter and fiscal year ended September 30, 2017. HIGHLIGHTS Quarter ended September 30,...
Stericycle Declares Dividend on Mandatory Convertible Preferred Stock
Nov 29, 2017 21:02 pm UTC| Business
LAKE FOREST, Ill., Nov. 29, 2017 -- Stericycle, Inc. (NASDAQ:SRCL) today announced that its board of directors has declared a dividend of $13.125 per share on the company’s 5.25% Series A Mandatory Convertible Preferred...
Genesis Healthcare, Inc. Receives Continued Listing Standard Notice From the NYSE
Nov 29, 2017 21:01 pm UTC| Business
KENNETT SQUARE, Pa., Nov. 29, 2017 -- Genesis HealthCare (“Genesis”) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced that it received written notification from the New York...
Descartes Reports Fiscal 2018 Third Quarter Financial Results
Nov 29, 2017 21:01 pm UTC| Business
WATERLOO, Ontario, Nov. 29, 2017 -- The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2018 third quarter (Q3FY18) ended October 31, 2017. All financial results...
Nov 29, 2017 20:48 pm UTC| Business
HOUSTON, Nov. 29, 2017 -- Synthesis Energy Systems, Inc. (SES) (NASDAQ:SYMX), a global leader in the clean and efficient production of low-cost synthesis gas for high value energy and chemical products, announced that...
Nov 29, 2017 20:42 pm UTC| Business
Company Announcement Genmab to receive USD 20 million milestone payment from Janssen Milestone triggered by progress in the Phase III study of daratumumab in combination with cyclophosphamide, bortezomib and...